At a glance
ClinicalIndex Comparison RecordN/ACompleted· 3,954 enrolled
Drug / intervention
LABA and the LAMA tiotropium (LABA-TIO) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparative Effectiveness of Combination Therapies in COPD
In Brief
An observational study evaluating LABA and the LAMA tiotropium (LABA-TIO) and LABA and an ICS (LABA-ICS) for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 3,954 participants across 1 site.
Detailed Summary
To assess the effectiveness of maintenance treatment of Chronic obstructive pulmonary disease (COPD) with the combination of a long-acting bronchodilators (LABA and the long-acting muscarinic antagonists (LAMA) tiotropium (LABA-TIO)) compared with the combination of a LABA and an ICS (LABA-ICS) on the time to COPD exacerbation.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartDec 2017
First PostedDec 2017
Primary CompletionDec 2017
TodayJul 2026
First PostedDec 18, 2017
Enrollment StartDec 1, 2017
Primary CompletionDec 31, 2017
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 8.5 years ago
Interventions
LABA and the LAMA tiotropium (LABA-TIO)drug
combinational drug
LABA and an ICS (LABA-ICS)drug
combinational drug